Rule 8 statement re Panmure G

RNS Number : 2269T
Evolution Group PLC
23 September 2010
 



The Evolution Group Plc

23 September 2010

THE EVOLUTION GROUP PLC

For Immediate Release

Evolution Group Plc ("Evolution" or the "Company")

Rule 8 statement relating to Panmure Gordon & Co plc ("Panmure Gordon")

Further to its announcement earlier today, Evolution provides the following information in relation to the requirements of Rule 8 of the City Code on Takeovers and Mergers (the "Code").

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified.

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

In accordance with Rule 2.10 of the Code, the Company announces that at the close of business on 22 September 2010, the Company had the following relevant securities (as defined under the Code) in issue and admitted to the official list and to trading on the main market of the London Stock Exchange: 232,289,024 ordinary shares of one pence each. The ISIN reference number for these securities is GB0030221864.

For Enquiries:

 

Evolution

Alex Snow, Chief Executive Officer                              0207 071 4300

 

Investor Relations

Charles Cooke, Director Merlin Financial                      0207 726 8400


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRKKNDQPBKDKCB

Companies

Evgen Pharma (EVG)
UK 100

Latest directors dealings